tiprankstipranks
Reckitt (GB:RKT)
LSE:RKT
Want to see GB:RKT full AI Analyst Report?

Reckitt (RKT) AI Stock Analysis

338 Followers

Top Page

GB:RKT

Reckitt

(LSE:RKT)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
5,099.00 p
▼(-1.56% Downside)
Action:DowngradedDate:03/07/26
The score is driven primarily by improved financial performance (notably profitability and lower leverage) and supportive valuation (moderate P/E and solid yield). These are tempered by weak technicals (below key moving averages with negative momentum) and earnings-call-flagged near-term pressures on cash flow, leverage, and 2026 margin/EPS visibility.
Positive Factors
Margin Expansion & Profitability
A meaningful step-up in 2025 margins demonstrates stronger pricing power, category mix and effectiveness of cost programs. Sustained margins support durable cash generation, fund brand investment and shareholder returns, and increase resilience versus cyclical volume swings.
Negative Factors
Cash Conversion Weakness
Weaker cash conversion despite higher reported earnings signals working-capital or timing pressures that can limit free cash available for capex, dividends and buybacks. If persistent, this constrains financial flexibility and raises execution risk for restructuring plans.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Expansion & Profitability
A meaningful step-up in 2025 margins demonstrates stronger pricing power, category mix and effectiveness of cost programs. Sustained margins support durable cash generation, fund brand investment and shareholder returns, and increase resilience versus cyclical volume swings.
Read all positive factors

Reckitt (RKT) vs. iShares MSCI United Kingdom ETF (EWC)

Reckitt Business Overview & Revenue Model

Company Description
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; di...
How the Company Makes Money
Reckitt makes money primarily by selling branded consumer packaged goods at scale. Revenue is generated from (1) consumer health products (including OTC medicines and wellness brands) sold through pharmacies, mass retailers, and online; (2) hygien...

Reckitt Earnings Call Summary

Earnings Call Date:Mar 05, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Jul 29, 2026
Earnings Call Sentiment Positive
The call presents a predominantly positive operational picture driven by strong Emerging Markets growth, margin expansion, tangible returns to shareholders, successful innovation and early results from supply chain investments. However, meaningful near-term headwinds remain: a weak Europe and soft seasonal OTC, modest EPS growth (partly due to tax and FX), one-off impacts and stranded costs from the Essential Home divestment, and a temporary rise in leverage and fixed-cost pressure in 2026. Management is confident the Fuel for Growth program and continued investment will offset many of these pressures over time and deliver medium-term targets.
Positive Updates
Core and Group Revenue Growth
Core Reckitt like-for-like net revenue grew 5.2% in 2025 (volume +1.5%, price/mix +3.7%); group net revenue increased 5.0%. Excluding seasonal OTC, Core Reckitt grew 7.0% year-on-year.
Negative Updates
Weakness in Europe
Europe net revenue declined 1.4% for the year with volumes down 3.1%; category growth slowed to broadly flat and promotional intensity increased, weighing on growth and shares in the region.
Read all updates
Q4-2025 Updates
Negative
Core and Group Revenue Growth
Core Reckitt like-for-like net revenue grew 5.2% in 2025 (volume +1.5%, price/mix +3.7%); group net revenue increased 5.0%. Excluding seasonal OTC, Core Reckitt grew 7.0% year-on-year.
Read all positive updates
Company Guidance
Reckitt guided Core Reckitt like‑for‑like net revenue growth of 4–5% for 2026 (reiterating its medium‑term target) with Q1 expected below the full‑year pace; Mead Johnson Nutrition is expected to grow low single digits LFL in 2026 but to see a mid‑single‑digit revenue decline in Q1 (lapping a 2025 retailer inventory build). Group adjusted operating profit should largely offset stranded costs from the Essential Home divestment via the Fuel for Growth program (group adjusted operating profit margin exited 2025 at 24.9%); the Fuel for Growth envelope remains c. GBP1bn and Reckitt now expects to exit 2027 with a fixed cost base below 19% (group fixed costs were 19.4% in 2025). CapEx guidance for 2026 is around 4% of revenue (2025 CapEx was GBP592m); free cash flow was GBP1.7bn in 2025 (71% conversion) and is expected to be similar in 2026–27 while restructuring runs, then normalise after end‑2027; net debt/EBITDA closed 2025 at 1.6x (c.2x after the GBP1.6bn special dividend) and is expected to rise toward ~2.5x by H1 2026 before trending down. Capital return remains active (FY dividend proposed +5%, 2025 returns totaled GBP2.3bn including GBP900m buybacks and a GBP1.6bn special dividend); EPS will receive Vestacy‑related income (USD300m vendor loan note, 30% associate stake and ~GBP25m pretax services) and benefit from share consolidation/buybacks but faces a 2026 dilution headwind from the Essential Home divestment; tax guidance is around 27% and c.55% of FX/commodity exposures are hedged over a 12‑month horizon.

Reckitt Financial Statement Overview

Summary
Strong 2025 step-up in profitability and a materially improved leverage profile support a higher score, but cash flow did not scale with the earnings surge (lower cash conversion and weaker operating cash flow), and results show some historical volatility.
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
63
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.21B14.17B14.61B14.45B13.23B
Gross Profit8.63B8.60B8.76B8.36B7.69B
EBITDA4.22B2.95B3.19B3.90B465.00M
Net Income3.18B1.43B1.64B2.33B-32.00M
Balance Sheet
Total Assets25.07B25.30B27.14B28.74B26.95B
Cash, Cash Equivalents and Short-Term Investments1.95B760.00M1.39B1.16B1.26B
Total Debt8.43B8.66B8.54B8.88B9.56B
Total Liabilities17.29B18.58B18.67B19.26B19.49B
Stockholders Equity7.75B6.70B8.45B9.44B7.40B
Cash Flow
Free Cash Flow1.76B2.22B2.19B1.95B1.32B
Operating Cash Flow2.30B2.68B2.64B2.40B1.70B
Investing Cash Flow1.20B-396.00M-466.00M-139.00M239.00M
Financing Cash Flow-2.43B-2.71B-1.81B-2.38B-2.29B

Reckitt Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5180.00
Price Trends
50DMA
5569.66
Negative
100DMA
5728.32
Negative
200DMA
5591.80
Negative
Market Momentum
MACD
-106.73
Negative
RSI
48.28
Neutral
STOCH
14.83
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RKT, the sentiment is Positive. The current price of 5180 is above the 20-day moving average (MA) of 5045.79, below the 50-day MA of 5569.66, and below the 200-day MA of 5591.80, indicating a neutral trend. The MACD of -106.73 indicates Negative momentum. The RSI at 48.28 is Neutral, neither overbought nor oversold. The STOCH value of 14.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:RKT.

Reckitt Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
£15.20B17.3326.03%1.96%9.27%16.35%
74
Outperform
£21.47B12.5842.31%5.57%2.69%-16.50%
71
Outperform
£93.54B20.3326.01%3.85%-16.19%8.30%
70
Outperform
£93.11B11.8716.33%5.67%-0.99%159.02%
69
Neutral
£12.93B7.898.44%2.98%-2.16%-24.87%
66
Neutral
£30.61B12.3038.45%3.44%0.25%131.13%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:RKT
Reckitt
4,721.00
212.11
4.70%
GB:ABF
Associated British Foods
1,819.50
-353.28
-16.26%
GB:BATS
British American Tobacco
4,236.00
1,272.10
42.92%
GB:CCH
Coca Cola HBC
4,155.00
448.49
12.10%
GB:IMB
Imperial Brands
2,737.00
-102.68
-3.62%
GB:ULVR
Unilever
4,226.00
-584.15
-12.14%

Reckitt Corporate Events

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 176,000 Shares, Updates Voting Rights Count
Neutral
Apr 27, 2026
Reckitt Benckiser Group PLC has repurchased 176,000 of its ordinary shares from Deutsche Bank’s London branch under a shareholder-authorised buyback programme and will hold the shares in treasury. Following this transaction, Reckitt’s ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Expands Treasury Stock With Latest Share Buyback
Positive
Apr 24, 2026
Reckitt Benckiser Group plc has repurchased 178,221 ordinary shares on 23 April 2026 from Deutsche Bank’s London branch under a shareholder-approved buyback programme, paying a volume-weighted average price of 4,756.82 pence per share. The s...
Stock BuybackRegulatory Filings and Compliance
Reckitt Advances Buyback With New Treasury Share Purchase
Neutral
Apr 24, 2026
Reckitt Benckiser Group has continued its share buyback activity, repurchasing 178,221 ordinary shares on 23 April 2026 through Deutsche Bank under an existing shareholder authority. The shares, bought at a volume-weighted average price of 4,756.8...
Executive/Board Changes
Reckitt Non-Executive Director Harry Kirsch Joins Galderma Board
Neutral
Apr 23, 2026
Reckitt Benckiser Group plc has announced that non-executive director Harry Kirsch has joined the board of Swiss-listed dermatology company Galderma as a director, effective 22 April 2026. The cross-board appointment signals an additional external...
Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Buys Back 192,000 Shares for Treasury Holding
Neutral
Apr 23, 2026
Reckitt Benckiser Group has repurchased 192,000 of its ordinary shares on 22 April 2026 from Deutsche Bank’s London branch under an existing shareholder authority. The shares, bought at a volume‑weighted average price of 4,664.53 pence...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 160,000 Shares, Updates Voting Rights Total
Positive
Apr 22, 2026
Reckitt Benckiser Group has continued its capital management programme by repurchasing 160,000 ordinary shares on 21 April 2026 from Deutsche Bank’s London branch, at prices ranging between 4,953.00p and 5,104.00p per share, to be held in tr...
Business Operations and StrategyStock BuybackFinancial Disclosures
Reckitt Holds 2026 Outlook as Emerging Markets Offset Seasonal and Geopolitical Headwinds
Neutral
Apr 22, 2026
Reckitt reported that Core operations delivered 1.3% like-for-like net revenue growth in the first quarter of 2026, with Emerging Markets up 7.6% and double‑digit gains in China and India offsetting weakness in Europe, a soft cold and flu se...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 155,000 Shares for Treasury, Adjusting Voting Capital
Neutral
Apr 21, 2026
Reckitt Benckiser Group PLC has repurchased 155,000 of its ordinary shares from Deutsche Bank’s London branch under an existing shareholder-authorised buyback programme, paying a volume-weighted average price of 5,112.87 pence per share, wit...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Continues Capital Management With Latest Share Buyback
Positive
Apr 20, 2026
Reckitt Benckiser Group plc has executed a share buyback transaction, repurchasing 91,339 ordinary shares from Deutsche Bank’s London branch under previously granted shareholder authority. The shares, bought at a volume-weighted average pric...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 159,000 Shares, Updates Voting Rights Count
Positive
Apr 17, 2026
Reckitt Benckiser has continued its share buyback programme, purchasing 159,000 ordinary shares on 16 April 2026 from Deutsche Bank’s London branch under the authority granted by shareholders in January 2026. The repurchased shares, acquired...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Adds to Treasury Stock with Latest Share Buyback
Neutral
Apr 16, 2026
Reckitt Benckiser Group has continued its share buyback activity, repurchasing 158,010 ordinary shares on 15 April 2026 from Deutsche Bank’s London branch under an existing shareholder authority. The shares, bought at a volume-weighted avera...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Adds to Treasury Stock with New Share Buyback
Positive
Apr 15, 2026
Reckitt Benckiser Group has repurchased 157,000 of its ordinary shares on 14 April 2026, at prices between 5,058.00p and 5,122.00p, with a volume-weighted average price of 5,084.57p per share. The shares, bought from Deutsche Bank’s London b...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 156,000 Shares, Updates Voting Rights Count
Neutral
Apr 14, 2026
Reckitt Benckiser Group plc has repurchased 156,000 of its ordinary shares from Deutsche Bank AG’s London branch under a shareholder-approved buyback authority, with the shares to be held in treasury. Following this transaction, Reckitt now ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Expands Treasury Stock with New Share Buyback
Positive
Apr 10, 2026
Reckitt Benckiser Group has repurchased 154,000 of its ordinary shares on 7 April 2026 from Deutsche Bank AG’s London branch under a shareholder-approved buyback programme, with prices ranging between 5,122.00p and 5,254.00p and a volume-wei...
Stock Buyback
Reckitt Updates Share Count After Latest Buyback Transaction
Neutral
Apr 10, 2026
Reckitt Benckiser Group plc has repurchased 154,400 ordinary shares on 9 April 2026 from Deutsche Bank AG’s London branch under a previously announced buyback instruction, with the shares to be held in treasury. Following this transaction, R...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Buys Back 140,000 Shares, Updates Voting Rights
Positive
Apr 9, 2026
Reckitt Benckiser Group has continued its capital management programme with the repurchase of 140,000 ordinary shares on 8 April 2026, at a volume-weighted average price of 5,354.89 pence, with the shares to be held in treasury. Following this tra...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 155,000 Shares, Updates Voting Rights Count
Positive
Apr 7, 2026
Reckitt Benckiser Group plc has repurchased 155,000 of its ordinary shares on 2 April 2026 from Deutsche Bank AG, London Branch, under a shareholder-approved buyback authority, with prices ranging between 5,124.00 pence and 5,202.00 pence per shar...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 155,000 Shares, Updates Voting Rights Total
Positive
Apr 2, 2026
Reckitt Benckiser Group plc has repurchased 155,000 of its ordinary shares on 1 April 2026 from Deutsche Bank’s London branch under an existing shareholder-authorised buyback programme, with the shares to be held in treasury. Following this ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 155,000 Shares, Updates Voting Rights Total
Positive
Apr 2, 2026
Reckitt Benckiser Group has continued its share buyback activity, purchasing 155,000 ordinary shares on 1 April 2026 from Deutsche Bank’s London branch under previously granted shareholder authority. The shares, which will be held in treasur...
Regulatory Filings and Compliance
Reckitt Updates Share Capital and Voting Rights Totals
Neutral
Apr 1, 2026
Reckitt Benckiser Group plc has reported that, as of 31 March 2026, it has 674,005,752 issued ordinary shares, of which 30,017,464 are held in treasury and therefore carry no voting rights. This leaves a total of 643,988,288 voting rights attached...
Business Operations and StrategyStock Buyback
Reckitt Tightens Free Float With Targeted Share Buyback
Positive
Apr 1, 2026
Reckitt Benckiser Group has repurchased 155,000 of its ordinary shares on 31 March 2026 from Deutsche Bank AG’s London branch under a previously authorised buyback programme, with the shares to be held in treasury. Following this transaction...
Stock BuybackRegulatory Filings and Compliance
Reckitt Tightens Free Float with New Treasury Share Buyback
Positive
Mar 31, 2026
Reckitt Benckiser Group has repurchased 155,300 of its ordinary shares on 30 March 2026 through Deutsche Bank, paying a volume-weighted average price of 5,146.13 pence per share and holding the bought-back stock in treasury. Following this transac...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 156,000 Shares, Updates Voting Rights Count
Neutral
Mar 30, 2026
Reckitt Benckiser Group plc has repurchased 156,000 of its ordinary shares on 27 March 2026 from Deutsche Bank AG’s London branch under an existing shareholder-authorised buyback programme, with the shares to be held in treasury. Following t...
Stock BuybackRegulatory Filings and Compliance
Reckitt Updates Voting Rights After Latest Share Buyback
Neutral
Mar 27, 2026
Reckitt Benckiser Group has repurchased 154,697 ordinary shares on 26 March 2026 under its shareholder-approved buyback authority, with the shares to be held in treasury. Following this transaction, the company holds 29,861,464 shares in treasury ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Buys Back 155,000 Shares, Updates Voting Rights
Positive
Mar 26, 2026
Reckitt Benckiser has repurchased 155,000 ordinary shares from Deutsche Bank’s London branch under its shareholder-approved buyback authority, with the shares to be held in treasury. Following this transaction, the company holds 29,716,960 s...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 155,000 Shares for Treasury Holding
Neutral
Mar 26, 2026
Reckitt Benckiser Group has repurchased 155,000 ordinary shares on 25 March 2026 from Deutsche Bank’s London branch under its shareholder-approved buyback authority. The shares, bought at a volume-weighted average price of 5,092 pence, will ...
Executive/Board ChangesRegulatory Filings and Compliance
Reckitt executives retain shares after LTIP vesting and tax-related sales
Neutral
Mar 25, 2026
Reckitt Benckiser has reported changes in shareholdings of senior executives following the vesting of awards under its 2015 Long Term Incentive Plan. Chief executive Kris Licht, chief financial officer Shannon Eisenhardt and Nutrition president Su...
Financial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Reckitt Publishes 2025 Annual Report and Sets Date for 2026 AGM
Neutral
Mar 25, 2026
Reckitt Benckiser Group has published its Annual Report and Financial Statements for the year ended 31 December 2025, along with the notice of its 2026 Annual General Meeting, on the company’s website and via the UK National Storage Mechanis...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Boosts Treasury Stock with Latest Share Buyback
Positive
Mar 25, 2026
Reckitt Benckiser Group has repurchased 156,500 of its ordinary shares on 24 March 2026 from Deutsche Bank’s London branch under an existing shareholder-authorised buyback programme, paying a volume-weighted average price of 5,100.08 pence p...
Stock BuybackRegulatory Filings and Compliance
Reckitt Boosts Treasury Stock With Latest Share Buyback
Positive
Mar 24, 2026
Reckitt Benckiser Group has repurchased 157,000 ordinary shares from Deutsche Bank AG’s London branch under its shareholder-approved buyback authority, with the shares to be held in treasury. The transaction, executed on 23 March 2026 at a v...
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Reckitt Aligns Executive Pay With Long-Term Performance via Deferred Share Awards
Positive
Mar 23, 2026
Reckitt Benckiser has granted conditional share awards under its Deferred Bonus Plan to senior leadership, including CEO Kris Licht, CFO Shannon Eisenhardt and Nutrition President Susan Sholtis. The awards, which carry nil consideration and will v...
Business Operations and StrategyStock Buyback
Reckitt Adds to Treasury Stock With New Share Buyback
Positive
Mar 23, 2026
Reckitt Benckiser Group plc has repurchased 154,560 of its ordinary shares from Deutsche Bank AG’s London branch under an existing shareholder-authorised buyback programme. The shares, acquired at a volume-weighted average price of 5,142.73 ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Updates Share Count After Latest Buyback Transaction
Positive
Mar 20, 2026
Reckitt Benckiser Group has repurchased 153,900 ordinary shares on 19 March 2026 from Deutsche Bank AG, London Branch, under an existing shareholder-approved buyback authority, and will hold these shares in treasury. Following this transaction, Re...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Buys Back 140,000 Shares, Updates Voting Rights
Positive
Mar 19, 2026
Reckitt Benckiser Group has repurchased 140,000 ordinary shares from Deutsche Bank’s London branch under a previously authorised buyback programme, paying a volume-weighted average price of 5,347.40 pence per share and placing the shares int...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 127,000 Shares, Updates Voting Rights Count
Positive
Mar 18, 2026
Reckitt Benckiser Group has repurchased 127,000 of its ordinary shares on 17 March 2026 from Deutsche Bank AG’s London branch under a previously authorised buyback programme, with the shares to be held in treasury. Following this transaction...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt updates voting rights after latest share buyback
Positive
Mar 16, 2026
Reckitt Benckiser Group has repurchased 138,000 of its ordinary shares from Deutsche Bank AG’s London branch under shareholder authority granted in January 2026, with the shares to be held in treasury. Following this transaction, Reckitt now...
Business Operations and StrategyExecutive/Board Changes
Reckitt links 2026 executive LTIP awards to growth, returns and sustainability
Positive
Mar 13, 2026
Reckitt has granted new 2026 Long Term Incentive Plan awards to CEO Kris Licht, CFO Shannon Eisenhardt and Nutrition President Susan Sholtis, comprising performance share options and performance share awards at an exercise price of £55.24 per...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 140,000 Shares, Raises Treasury Stock to 29.4 Million
Positive
Mar 13, 2026
Reckitt Benckiser Group has repurchased 140,000 ordinary shares on 12 March 2026 from Deutsche Bank’s London branch under an existing shareholder authority, with the shares to be held in treasury. The move lifts treasury holdings to 29,371,2...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 138,000 Shares, Updates Voting Rights Base
Neutral
Mar 12, 2026
Reckitt Benckiser Group has repurchased 138,000 of its ordinary shares from Deutsche Bank’s London branch under its shareholder-approved buyback authority, with the shares to be held in treasury. Following this transaction, Reckitt holds 29....
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Updates Voting Rights After Fresh Share Buyback
Positive
Mar 11, 2026
Reckitt Benckiser Group has repurchased 127,000 of its ordinary shares on 10 March 2026 from Deutsche Bank’s London branch under an existing shareholder authority, paying a volume-weighted average price of 5,489.76 pence and placing the acqu...
Regulatory Filings and Compliance
Reckitt Discloses LTIP Share Vesting and Sale by Nutrition President
Neutral
Mar 9, 2026
Reckitt Benckiser has disclosed a change in shareholdings by Susan Sholtis, its President Nutrition, following the vesting of a long-term incentive award. A conditional award of 4,500 shares granted in March 2024 under the company’s 2015 Lon...
Business Operations and StrategyStock Buyback
Reckitt launches £540m third tranche of £1bn share buyback
Positive
Mar 9, 2026
Reckitt Benckiser Group plc has launched the third tranche of its previously announced £1 billion share buyback programme, committing up to a further £540 million to be returned to shareholders by no later than 27 July 2026. The repurcha...
Business Operations and StrategyExecutive/Board Changes
Reckitt refreshes board with senior hires from Novartis and Smith+Nephew
Positive
Mar 5, 2026
Reckitt Benckiser has announced changes to its board, appointing Novartis CFO Harry Kirsch and Smith+Nephew CEO Deepak Nath as non-executive directors effective 1 April 2026, with Kirsch also set to join the audit committee from May. Both bring ex...
Business Operations and StrategyDividendsFinancial DisclosuresRegulatory Filings and Compliance
Reckitt posts 2025 results and lifts dividend by 5%
Positive
Mar 5, 2026
Reckitt Benckiser has published its full-year results for 2025 and confirmed that the complete statement is available on its website and through the UK financial regulator’s storage mechanism. The disclosure underlines the company’s co...
Regulatory Filings and Compliance
Reckitt Updates Total Voting Rights to 644.96 Million Shares
Neutral
Mar 2, 2026
Reckitt Benckiser Group plc has confirmed its current capital structure under U.K. disclosure rules, stating that as of 27 February 2026 it has 674,005,752 issued ordinary shares, of which 29,043,683 are held in treasury without voting rights. Thi...
Regulatory Filings and Compliance
Reckitt CEO and CFO Boost Holdings Through Dividend Reinvestment Plan
Positive
Feb 23, 2026
Reckitt disclosed that chief executive Kris Licht acquired 2,109 ordinary shares through the company’s Dividend Reinvestment Plan on 20 February, at a price of £64.61933 per share, in a transaction on the London Stock Exchange. Chief fi...
Business Operations and Strategy
Reckitt Leaders to Address CAGNY Without New Financial Disclosures
Neutral
Feb 19, 2026
Reckitt said its chief executive, Kris Licht, and chief financial officer, Shannon Eisenhardt, will address the Consumer Analyst Group of New York Conference in Orlando, underscoring the company’s efforts to engage closely with the investmen...
Delistings and Listing ChangesRegulatory Filings and ComplianceStock Split
Reckitt Share Consolidation Takes Effect as New Voting Capital Confirmed
Neutral
Feb 2, 2026
Reckitt Benckiser Group has made effective a previously approved share consolidation linked to its special dividend, with the company’s new ordinary shares admitted today to the FCA’s Official List and to trading on the London Stock Ex...
Business Operations and StrategyStock Buyback
Reckitt Completes Second Tranche of £1 Billion Share Buyback Programme
Positive
Feb 2, 2026
Reckitt Benckiser Group plc has completed the second tranche of its previously announced £1 billion share buyback programme, purchasing 3,461,470 ordinary shares between 22 October 2025 and 28 January 2026 at an average price of £59.46, ...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,785 Shares, Sets New Voting Rights Total
Neutral
Jan 29, 2026
Reckitt Benckiser Group plc has repurchased 58,785 of its ordinary shares from BNP Paribas SA under its shareholder-approved buyback authority, paying a volume-weighted average price of 5,953.57 pence per share, with the shares to be held in treas...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,860 Shares, Updates Voting Rights Count
Neutral
Jan 28, 2026
Reckitt Benckiser Group plc has repurchased 58,860 of its ordinary shares from BNP Paribas SA under an existing shareholder-authorised buyback programme, paying a volume-weighted average price of 5,945.65 pence per share, with the shares to be hel...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 07, 2026